tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XERS Stock Latest News

Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
RatingsXeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
6d ago
XERS
Xeris Biopharma initiated with an Overweight at Barclays
PremiumThe Fly
Xeris Biopharma initiated with an Overweight at Barclays
1M ago
XERS
Xeris Pharmaceuticals Secures Patent Allowance for XP-8121
PremiumCompany Announcements
Xeris Pharmaceuticals Secures Patent Allowance for XP-8121
1M ago
8K
XERS
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
PremiumThe Fly
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
1M ago
XERS
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
PremiumThe Fly
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
2M ago
XERS
Xeris Pharmaceuticals: Strong Growth Potential and First Profitable Quarter Drive Buy Rating
PremiumRatingsXeris Pharmaceuticals: Strong Growth Potential and First Profitable Quarter Drive Buy Rating
2M ago
XERS
Xeris Biopharma Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Xeris Biopharma Reports Strong Q3 2025 Financial Results
2M ago
XERS
Xeris Biopharma Reports Record Revenue Growth in Earnings Call
Premium
Company Announcements
Xeris Biopharma Reports Record Revenue Growth in Earnings Call
2M ago
XERS
Xeris Biopharma reports Q3 EPS 0c, consensus 0c
PremiumThe Fly
Xeris Biopharma reports Q3 EPS 0c, consensus 0c
2M ago
XERS
Xeris Biopharma price target raised to $18 from $8 at Oppenheimer
PremiumThe Fly
Xeris Biopharma price target raised to $18 from $8 at Oppenheimer
3M ago
XERS
American Regent launches Gvoke VialDx
PremiumThe Fly
American Regent launches Gvoke VialDx
5M ago
XERS
Xeris Biopharma announces Orange Book listing of U.S. patent for Recorlev
PremiumThe Fly
Xeris Biopharma announces Orange Book listing of U.S. patent for Recorlev
5M ago
XERS
Xeris Pharmaceuticals Reports Record Revenue and Growth
PremiumCompany AnnouncementsXeris Pharmaceuticals Reports Record Revenue and Growth
5M ago
XERS
Xeris Pharmaceuticals: Undervalued Growth Potential Driven by Recorlev and XP-8121
Premium
Ratings
Xeris Pharmaceuticals: Undervalued Growth Potential Driven by Recorlev and XP-8121
5M ago
XERS
Xeris Biopharma assumed with a Buy at H.C. Wainwright
Premium
The Fly
Xeris Biopharma assumed with a Buy at H.C. Wainwright
5M ago
XERS
Xeris Biopharma price target raised to $8 from $7 at Oppenheimer
PremiumThe Fly
Xeris Biopharma price target raised to $8 from $7 at Oppenheimer
5M ago
XERS
Xeris Biopharma Reports Strong Q2 2025 Results
PremiumCompany Announcements
Xeris Biopharma Reports Strong Q2 2025 Results
5M ago
XERS
Xeris Pharmaceuticals Completes Promising Phase 2 Study on Hypothyroidism Treatment
PremiumCompany Announcements
Xeris Pharmaceuticals Completes Promising Phase 2 Study on Hypothyroidism Treatment
7M ago
XERS
Xeris Pharmaceuticals Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Xeris Pharmaceuticals Holds 2025 Annual Stockholders Meeting
7M ago
8K
XERS
Xeris Pharmaceuticals Hosts Analyst and Investor Day
PremiumCompany AnnouncementsXeris Pharmaceuticals Hosts Analyst and Investor Day
8M ago
8K
XERS
Xeris Biopharma to hold analyst and investor day
Premium
The Fly
Xeris Biopharma to hold analyst and investor day
8M ago
XERS
Positive Outlook and Strategic Advancements Drive Buy Rating for Xeris Pharmaceuticals
Premium
Ratings
Positive Outlook and Strategic Advancements Drive Buy Rating for Xeris Pharmaceuticals
8M ago
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >